Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer

Journal of Clinical Oncology

Volumn 17, Issue 2, 1999, Pages 638-644

  Haraf, Daniel J ^a   Kies, Merrill ^a   Rademaker, Alfred W ^a   Stenson, Kerstin ^a   Mittal, Bharat ^a   Pelzer, Harold ^a   Wenig, Barry ^a   Witt, Mary Ellyn ^a   Sulzen, Laura ^a   Weichselbaum, Ralph R ^a   Vokes, Everett E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HYDROXYUREA;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; ORGAN PRESERVATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0032976376     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.2.638     Document Type: Article

References (15)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690, 1991
2. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial - EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
3. Haraf DJ, Vokes EE, Panje WR, et al: Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 14:419-426, 1991
4. Haraf DJ, Weichselbaum RR, Vokes EE: Reirradiation with concomitant chemotherapy of recurrent unresectable head and neck cancer: A potentially curable disease. Ann Oncol 7:913-918, 1996
5. Haraf DJ, Vokes EE, Weichselbaum RR, et al: Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor prognosis head and neck cancer. Laryngoscope 102:630-636, 1992
6. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
7. Schuller DE, Metch B, Mattox D, et al: Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98:1205-1211, 1988
8. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report of the Head and Neck Contracts Program. Cancer 60:301-311, 1987
9. Jacobs C, Mauch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838-847, 1990
10. Mendenhall WM, Parsons JT, Mancuso AA, et al: Definitive radiotherapy for T3 squamous carcinoma of the glottic larynx. J Clin Oncol 15:2394-2402, 1997
11. Shah JP, Karnell LH, Hoffman HT, et al: Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 123:475-483, 1997
12. Wong WW, Mick R, Haraf DJ, et al: Time-dose relationship for tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 29:153-162, 1994
13. Merlano M, Vitale V, Russo R, et al: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121, 1992
14. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
15. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998